Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Len Tanaka"'
Autor:
Malia Rasa MD, James Musgrave MD, Keith Abe MD, Len Tanaka MD, Konstantine Xoinis MD, Bruce Shiramizu MD, Gretchen Foskett MD, Rhiana Lau MD
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 5 (2017)
Hemolytic uremic syndrome (HUS) can be classified as typical and atypical, and the treatment recommendations currently differ between the 2 types. Eculizumab is recommended as first-line treatment for atypical HUS; however, its use in typical HUS has
Externí odkaz:
https://doaj.org/article/a07ccabda34c4df2a092ad3e128164f3
Autor:
Nelly Gutierrez Martinez, Surabhi Khasgiwala, Len Tanaka, Aileen Tanaka, Konstantine Xoinis, John Harrington, Keith Abe, Rupert Chang, Prashant Purohit
Publikováno v:
Critical Care Medicine. 50:395-395
Publikováno v:
Critical Care Medicine. 49:429-429
Autor:
Brian Wu, Konstantine Xoinis, Matthew Careskey, Edward Fong, Danielle Levy, John Harrington, Len Tanaka, Prashant Purohit
Publikováno v:
Critical Care Medicine. 49:494-494
INTRODUCTION: We present a case of a medically nonadherent 16 years-old female with a history of moderate persistent asthma and vaping of nicotine and marijuana products who presented in severe respiratory distress during the COVID-19 pandemic She ha
Autor:
Keith Abe, John Harrington, Marina Nogues, Rupert Chang, Natascha Ching, Len Tanaka, Marian E. Melish, Prashant Purohit
Publikováno v:
Critical Care Medicine. 49:388-388
Autor:
Malia, Rasa, James, Musgrave, Keith, Abe, Len, Tanaka, Konstantine, Xoinis, Bruce, Shiramizu, Gretchen, Foskett, Rhiana, Lau
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports
Hemolytic uremic syndrome (HUS) can be classified as typical and atypical, and the treatment recommendations currently differ between the 2 types. Eculizumab is recommended as first-line treatment for atypical HUS; however, its use in typical HUS has
Autor:
James Musgrave, Malia Rasa, Gretchen Foskett, Konstantine Xoinis, Rhiana Lau, Len Tanaka, Keith Abe, Bruce Shiramizu
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports. 5:232470961774114
Hemolytic uremic syndrome (HUS) can be classified as typical and atypical, and the treatment recommendations currently differ between the 2 types. Eculizumab is recommended as first-line treatment for atypical HUS; however, its use in typical HUS has
Publikováno v:
ASAIO Journal; 2024 Supplement, Vol. 70, p1-73, 73p
Publikováno v:
Army Reserve Magazine. Fall2005, Vol. 51 Issue 2, p20-21. 2p.
Autor:
Maruca, Regina Fazio, Milhaven, John M., Benasutti, Matt (AUTHOR), Lipton, Mark1 (AUTHOR), Hatsopoulos, George N.2 (AUTHOR), Beckert, Dorothy3 (AUTHOR), Miller, Warren D.3 (AUTHOR)
Publikováno v:
Harvard Business Review. Jan/Feb2000, Vol. 78 Issue 1, p25-35. 7p. 1 Black and White Photograph, 1 Graph.